Plant Advanced Technologies (PAT) s’introduit sur Alternext Paris

Raises €7 million, market capitalisation totals €26 million

Paris – 8 April 2015– EnterNext, the Euronext subsidiary dedicated to promoting and growing the market for SMEs[1],today congratulated Plant Advanced Technologies (PAT), a company specialised in identifying and producing rare plant molecules, on its successful listing on Alternext in Paris.

Founded in 2005, Plant Advanced Technologies (PAT) identifies, optimises and produces rare plant-based biomolecules for pharmaceuticals, cosmetics and green chemistry. The company’s product portfolio includes 26 active compounds, one already recognised internationally, and some 20 that will be on the market in the next five years for the treatment of aging, inflammation, cancer, Alzheimer’s disease and more. PAT's innovative technologies (PAT plant milking® and PAT Friday®) make for very strong growth potential in fast-growing markets.

Plant Advanced Techonologies (ticker symbol: ALPAT) was listed through the admission to trading of 867,521 ordinary shares, including 230,000 new shares issued under a Global Offering[2] after full exercise of the extension clause and before a potential over-allotment option.

The admission price and issue price of Plant Advanced Technologies was set at €30 per share. Market capitalisation on the day of listing was €26 million, and the operation raised a total of €6.9 million

Jean-Paul Fèvre, Plant Advanced Technologies’ co-founder and Chairman & CEO, said: “We are delighted that our listing has proved so popular, especially with such a large number of individual investors. Listing on Alternext is a milestone for PAT and will enable us to step up our growth. I would like to extend our sincere thanks to all of the individual and institutional investors who took part in this IPO for their trust and support.”

Eric Forest, Chairman and CEO of EnterNext, said “We are very pleased with successful listing of plant biotech specialist Plant Advanced Technologies. This transaction confirms the stockmarket’s appeal for innovative companies, allowing them to raise the capital they need to step up the pace of development. Plant Advanced Technologies is now part of a community of over 320 listed tech companies whose investor profiles are being boosted by tools developed by Euronext.”

_{[1]Small and medium-size companies

[2]TheGlobal Offering was made up of a Public Offering that included an Open Price Public Offering and a Global Placement with institutional investors in France and other countries}

Press Release Footer

About Euronext
Euronext is the leading pan-European market infrastructure, connecting European economies to global capital markets, to accelerate innovation and sustainable growth. It operates regulated exchanges in Belgium, France, Ireland, Italy, the Netherlands, Norway and Portugal. With more than 1,900 listed issuers and around €7.1 trillion in market capitalisation as of end March 2024, it has an unmatched blue-chip franchise and a strong diverse domestic and international client base. Euronext operates regulated and transparent equity and derivatives markets, one of Europe’s leading electronic fixed income trading markets and is the largest centre for debt and funds listings in the world. Its total product offering includes Equities, FX, Exchange Traded Funds, Warrants & Certificates, Bonds, Derivatives, Commodities and Indices. The Group provides a multi-asset clearing house through Euronext Clearing, and custody and settlement services through Euronext Securities central securities depositories in Denmark, Italy, Norway and Portugal. Euronext also leverages its expertise in running markets by providing technology and managed services to third parties. In addition to its main regulated market, it also operates a number of junior markets, simplifying access to listing for SMEs.
For the latest news, follow us on Twitter (twitter.com/euronext) and LinkedIn (linkedin.com/euronext).

_{Disclaimer

This press release is for information purposes only and is not a recommendation to engage in investment activities. This press release is provided “as is” without representation or warranty of any kind. While all reasonable care has been taken to ensure the accuracy of the content, Euronext does not guarantee its accuracy or completeness. Euronext will not be held liable for any loss or damages of any nature ensuing from using, trusting or acting on information provided. No information set out or referred to in this publication may be regarded as creating any right or obligation. The creation of rights and obligations in respect of financial products that are traded on the exchanges operated by Euronext’s subsidiaries shall depend solely on the applicable rules of the market operator. All proprietary rights and interest in or connected with this publication shall vest in Euronext.}

_{This press release speaks only as of this date. Euronext refers to Euronext N.V. and its affiliates. Information regarding trademarks and intellectual property rights of Euronext is located at www.euronext.com/terms-use.}